Woolworths (ASX:WOW) share price rises as boss courts API pharmacists

Woolworths shares are rising. The CEO is trying to woo API pharmacists.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Woolworths Group Ltd (ASX: WOW) share price is up 0.5% in early trading. The CEO of Woolworths is trying to convince Australian Pharmaceutical Industries Ltd (ASX: API) pharmacists to back the proposed takeover.

a business person in a suit and tie directs a pointed finger upwards with a graphic of a rising bar graph and an arrow heading upwards in line with the person's finger.

Image source: Getty Images

Woolworths CEO turns on the charm

Woolworths CEO Brad Banducci has written a letter to the pharmacists of API, which was published in the Pharmacy Daily.

It is down to the API board and shareholders that will decide which offer to accept – the one from Woolworths or from Wesfarmers Ltd (ASX: WES). However, both Woolworths and Wesfarmers want to win over the approval of pharmacists because they are key stakeholders.

In that letter, Mr Banducci aimed to "allay misplaced fears" about the company's intentions.

He said in the letter published on Pharmacy Daily that he understood that pharmacists had concerns about the bid considering the history of "perceived rivalry" between pharmacies and supermarkets. Mr Banducci said that the company will not look to change pharmacy location and ownership rules under his leadership.

Mr Banducci also wrote:

We are not here to disrupt the sector. We are here to help strengthen it. We strongly believe that a strong local community pharmacy health model is key to the health and wellbeing of our local communities and nation overall.

Through our proposal to acquire API, we are committed to helping those in the sector successfully operate their independently owned businesses.

Our investment revolves around bringing a set of capabilities we believe can help strengthen the existing vital role you play in the community for the benefit of both patients and customers.

Pharmacy Daily noted that the Woolworths CEO did not directly address concerns about how it would manage data from the Priceline Sister Club loyalty scheme, though Mr Banducci said the company would use its "extensive experience in areas such as digital, loyalty, payments, analytics and importantly, privacy."

The battle continues

According to reporting by The Australian, the Wesfarmers boss Rob Scott recently wrote to Trent Twomey, the president of the Pharmacy Guild, saying how it was committed to the community pharmacy model. Wesfarmers thinks it can deliver even better products and services to community pharmacists and Priceline franchisees that will help them be more competitive and create value over time.

Both Wesfarmers and Woolworths have lobbed bids for API. Woolworths' non-binding proposal is a cash offer of $1.75 per API share, which is $0.20 per share (or 12.9%) higher than the price that was agreed between API and Wesfarmers.

Both of them have outlined they will utilise their powerful logistics and other scale benefits to help API improve.

Woolworths share price snapshot

Over the last month, Woolworths shares have dropped around 5%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia owns and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Consumer Staples & Discretionary Shares

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Consumer Staples & Discretionary Shares

This ASX 200 director bought over $500k of his company's shares just in time for the dividend!

Investors typically draw comfort from seeing board directors spend their own money buying more shares in the ASX 200 companies…

Read more »

Woman thinking in a supermarket.
Opinions

Should I buy Woolworths shares at $37?

Are Woolworths shares worth putting in the shopping basket?

Read more »

A man looks at his laptop waiting in anticipation.
Investing Strategies

Big lesson from reporting season: STAY AWAY from these ASX shares, says expert

Plus the one stock you will want to buy now to hold through the imminent economic turbulence.

Read more »

waving the chequered flag
Broker Notes

Start your engines: Fund backs 2 ASX shares to finish line

This pair of companies reported outstanding results during last month's reporting season. Celeste is predicting further gains.

Read more »

A little girl holds broccoli over her eyes with a big happy smile.
Consumer Staples & Discretionary Shares

Goldman Sachs says buy Woolworths stock for reliable dividends AND 10% share price growth

This broker can't recommend Woolies shares highly enough.

Read more »

A woman is excited as she reads the latest rumour on her phone.
Consumer Staples & Discretionary Shares

Lovisa is a 'phenomenon': broker urges investors to buy shares

This could be one of the best growth shares around according to one leading broker.

Read more »

A middle-aged woman sits in contemplation over a tablet device considering information about ASX shares and deep in thought.
Consumer Staples & Discretionary Shares

4 directors have been buying up this ASX 200 stock since the company reported

Should insider buying drive investor attention towards this stock?

Read more »

A couple in a supermarket laugh as they discuss which fruits and vegetables to buy
Consumer Staples & Discretionary Shares

Coles stock can deliver golden combo of share price growth plus dividends: Citi

Consumers are still shopping with Coles, helping grow its earnings.

Read more »